Grant: Project Grant
University of British Columbia
$918,000.00
T-cell glyco-immune checkpoints as next-generation targets for cancer immunotherapy
EF 2023-24
Résumé
All of the cells in our body are coated with different types of sugar molecules. Cells in our immune system have ways of "tasting" these sugars. Some types of sugars taste good to our immune system, signaling that our cells are healthy and that everything is normal. Other sugars (like those attached to invading bacteria, viruses or cancer cells) taste bad to our immune cells, triggering them to activate and try to protect us from disease. Sometimes our cells can become altered in ways that lead them to produce different or abnormal types of sugar molecules on their surface. When this happens, it can lead our immune cells to
overlook unhealthy cells (in the case of cancer). This proposal aims to study a specific set of carbohydrates that regulate activity of important immune cells called T-cells. T-cells are highly significant because they are the primary type of cell involved in killing cancer cells before they can form a tumor. Our research aims to discover how sugars regulate the ability of T-cells to attack and destroy cancer. By better understanding this, we will then be able to design better immunotherapeutic strategies and improve treatment options for patients living with cancer.
Programme
Project Grant
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
501581
Name
Wisnovsky Simon
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Cancer Biology & Therapeutics
Projecttitle
T-cell glyco-immune checkpoints as next-generation targets for cancer immunotherapy
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$918,000
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Carbohydrates; Glycans; Immune Checkpoint Receptors; Melanoma; Siglecs; T-Cells; Tumor Immunology
Abstract
All of the cells in our body are coated with different types of sugar molecules. Cells in our immune system have ways of "tasting" these sugars. Some types of sugars taste good to our immune system, signaling that our cells are healthy and that everything is normal. Other sugars (like those attached to invading bacteria, viruses or cancer cells) taste bad to our immune cells, triggering them to activate and try to protect us from disease. Sometimes our cells can become altered in ways that lead them to produce different or abnormal types of sugar molecules on their surface. When this happens, it can lead our immune cells to
overlook unhealthy cells (in the case of cancer). This proposal aims to study a specific set of carbohydrates that regulate activity of important immune cells called T-cells. T-cells are highly significant because they are the primary type of cell involved in killing cancer cells before they can form a tumor. Our research aims to discover how sugars regulate the ability of T-cells to attack and destroy cancer. By better understanding this, we will then be able to design better immunotherapeutic strategies and improve treatment options for patients living with cancer.
Competitiondate
202403
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Wisnovsky, Simon; Williams, Karla
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $918,000~ $0~